Pentwater Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,933,200
| Closed | -$906M | – | 306 |
|
|
2021
Q2 | $906M | Buy |
4,933,200
+643,956
| +15% | +$118M | 7.48% | 2 |
|
|
2021
Q1 | $656M | Buy |
4,289,244
+1,328,244
| +45% | +$203M | 6.26% | 4 |
|
|
2020
Q4 | $463M | Buy |
+2,961,000
| New | +$463M | 5.59% | 5 |
|
|
2019
Q4 | – | Sell |
-22,500
| Closed | -$2.2M | – | 144 |
|
|
2019
Q3 | $2.2M | Buy |
+22,500
| New | +$2.2M | 0.03% | 52 |
|
|
2017
Q1 | – | Sell |
-6,000
| Closed | -$734K | – | 79 |
|
|
2016
Q4 | $734K | Buy |
+6,000
| New | +$734K | 0.01% | 49 |
|